China Biologic Products buy tamam
Start price
22.03.17
/
50%
€88.87
Target price
04.11.21
€123.21
Performance (%)
11.97%
End price
05.11.21
-
Summary
This prediction is currently being closed. The BUY prediction by tamam currently has a performance of 11.97%. tamam has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
China Biologic Products | - | - | - | - |
iShares Core DAX® | -3.033% | 0.651% | 12.268% | 18.187% |
iShares Nasdaq 100 | -3.554% | -3.007% | 27.682% | 47.279% |
iShares Nikkei 225® | -3.938% | 1.935% | 10.515% | 10.489% |
iShares S&P 500 | -1.517% | -0.602% | 25.859% | 45.572% |
Comments by tamam for this prediction
In the thread China Biologic Products diskutieren
CBPO's financials are solid; growth is healthy
tamam stimmt am 22.03.2017 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 136.6$ zu.
This stock offers remarkably low risk, but the upside will depend largely on the whims of the market.
At 10 price/sales, CBPO may seem expensive to most U.S investors, but quality comes at a premium. Even at these multiples, the stock represents a better value than many U.S firms in this tense political
climate.
In the thread Trading China Biologic Products
Die von tamam gewählte maximale Laufzeit wurde überschritten